Relay Therapeutics, Inc. (RLAY)
18.96
+0.47
(+2.54%)
USD |
NASDAQ |
Oct 02, 16:00
18.63
-0.33
(-1.74%)
After-Hours: 20:00
Relay Therapeutics Net Income (Quarterly) : -83.71M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -83.71M |
| March 31, 2026 | -73.29M |
| December 31, 2025 | -54.89M |
| September 30, 2025 | -74.15M |
| June 30, 2025 | -70.38M |
| March 31, 2025 | -77.06M |
| December 31, 2024 | -76.00M |
| September 30, 2024 | -88.10M |
| June 30, 2024 | -92.21M |
| March 31, 2024 | -81.39M |
| December 31, 2023 | -83.50M |
| September 30, 2023 | -65.73M |
| June 30, 2023 | -98.50M |
| March 31, 2023 | -94.24M |
| December 31, 2022 | -67.50M |
| Date | Value |
|---|---|
| September 30, 2022 | -84.17M |
| June 30, 2022 | -76.79M |
| March 31, 2022 | -62.05M |
| December 31, 2021 | -67.46M |
| September 30, 2021 | -60.83M |
| June 30, 2021 | -193.40M |
| March 31, 2021 | -42.18M |
| December 31, 2020 | 35.28M |
| September 30, 2020 | -36.08M |
| June 30, 2020 | -26.72M |
| March 31, 2020 | -24.89M |
| December 31, 2019 | -23.91M |
| September 30, 2019 | -19.67M |
| June 30, 2019 | -17.54M |
| March 31, 2019 | -14.18M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -9.605M |
| Karyopharm Therapeutics, Inc. | -67.02M |
| Spyre Therapeutics, Inc. | -36.20M |
| Akebia Therapeutics, Inc. | -8.908M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.35M |
| Total Expenses (Quarterly) | 84.06M |
| EPS Diluted (Quarterly) | -0.4127 |
| Enterprise Value | 3.263B |
| Gross Profit Margin (Quarterly) | -2.86% |
| Profit Margin (Quarterly) | -23.92K% |
| Earnings Yield | -8.26% |
| Normalized Earnings Yield | -8.264 |